Breast Cancer Pathophysiology Breast Cancer Advanced Pathophysiology Breast cancer is the most frequently diagnosed cancer in women worldwide. There are three general determinants associated with the cause of the disease: heredity factors, environmental factors, and hormonal factors. The risk of developing breast cancer increases with age, as 78% of cases are diagnosed in women ages 50 and older. Risk factors are distinguished by their respective etiological influences, such as family history, lifestyle, and

Partial Mastectomy- a procedure that remove part of the breast that contains the cancer and some tissue around the affected tissue. This type of surgery is also called a segmental mastectomy (Breast Cancer Treatment). In addition the National Cancer Institute reports that patients who undergo the aforementioned types of surgeries may also have some lymph nodes removed (Breast Cancer Treatment). Another type of surgery that does not conserve the breast is the

Breast Cancer Project Title: Women who chose Lumpectomy Over Prophylactic Mastectomy as Treatment for Early Stage Breast Cancer May have an Increased Risk for Post-Treatment Anxiety Regarding Fear of Recurrence. This proposed research plan will address the post treatment psychology of Stage I breast cancer patients who have received the less invasive breast retention surgery, referred to as lumpectomy. Do women with early stage breast cancer have more intrusive thoughts (stress) regarding recurrence

In this particular instance the place to start would be to launch an education program aimed at both patients and providers as to the importance of early detection screening for breast cancer. The goal would be to implement outreach strategies to improve access to screening for women who have rarely or never been screened. A second thing that would need to be done would be that of developing a

cancer genes that are associated with breast cancer. Scientists have known for years that the most common breast cancer genes are BRCA1 AND BRCA2, but there are many more than those two genes that scientists now much cope with. Another aspect of the focus is on whether or not to tell a woman that she has genes that might lead to breast cancer; the ethical questions are serious and

Epidemiology The Agency for Healthcare Research and Quality has issued its recommendations for breast cancer screening. In this article, they make a few different recommendations. First, they recommend screening for women 50-74 years. They note that women under 50 should make the choice for themselves as to whether or not they wish to begin screening. They note that there is little evidence to support screening age 75 onward. This body, however,